 NEW YORK, Dec. 02, 2021 GLOBE NEWSWIRE -- Brooklyn ImmunoTherapeutics, Inc . Nasdaq: BTX Brooklyn, a biopharmaceutical company focused on exploring the role that cytokine and gene editingcell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announced that President and CEO Howard Federoff, M.D., Ph.D. is scheduled to present at the following virtual conferences: 